Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib in advanced pancreatic cancer
NCT00226005Phase 2Completed
- Sponsor
- Pancreatic Cancer Research Team
- Start
- Dec 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in pancreatic adenocarcinoma (PDAC), sponsored by Pancreatic Cancer Research Team. Started Dec 2005; status: completed.
02
Drugs
vatalanib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00226005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226005.